相关实验视频

Updated: Jun 8, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

17.4K

[三阴性乳腺癌:现状和前景]

Fanny Le Du1, Emilie Moati2, Pauline Vaflard3

  • 1Département d'oncologie médicale, centre de lutte contre le cancer Eugène-Marquis, Rennes, France; Inserm UMR_S 1242, Oncogenesis Stress Signalling, université de Rennes, Rennes, France.

Bulletin du cancer
|November 7, 2024
PubMed
概括

三阴性乳腺癌 (TNBC) 是一种具有较差生存率的侵袭性亚型. 进步包括免疫疗法和向疗法,但TNBC仍然是一个重大的临床挑战,需要个性化治疗策略.

关键词:
抗体药物结合物 抗体药物结合物抗体是结合在一起的.乳腺癌 乳腺癌 乳腺癌乳腺癌是因为乳腺癌.化学疗法是一种化学疗法.免疫检查点抑制剂 免疫检查点抑制剂免疫疗法是一种免疫疗法.这是一种PARP抑制剂.这是一种PARP抑制剂.三重负数是指一个负数.三重负面是一个负面.

更多相关视频

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

5.9K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

2.5K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K